Download 1 - Heart

Non-invasive assessment of coronary artery disease in diabetes (hrt 122788)
Nico R Van de Veire, Roxana Djaberi, Joanne D Schuijf, Jeroen J. Bax
Web only refs
1
Camm AJ, Lüscher TF, Serruys PW, et al. The ESC textbook of cardiovascular
medicine. Malden, Mass. ; Oxford: Blackwell Pub./European Society of Cardiology
2006.
2
Di Carli MF, Hachamovitch R. Should we screen for occult coronary artery
disease among asymptomatic patients with diabetes? J Am Coll Cardiol 2005;45:50-3.
3
Hurst JW, O'Rourke RA. Hurst's the heart manual of cardiology. New York:
McGraw-Hill, Medical Pub. Division 2005.
4
Folsom AR, Aleksic N, Catellier D, et al. C-reactive protein and incident coronary
heart disease in the Atherosclerosis Risk In Communities (ARIC) study. Am Heart J
2002;144:233-8.
5
Ridker PM, Buring JE, Cook NR, et al. C-reactive protein, the metabolic
syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719
initially healthy American women. Circulation 2003;107:391-7.
6
Festa A, D'Agostino R, Jr., Howard G, et al. Chronic subclinical inflammation as
part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study
(IRAS). Circulation 2000;102:42-7.
7
Sander D, Schulze-Horn C, Bickel H, et al. Combined effects of hemoglobin A1c
and C-reactive protein on the progression of subclinical carotid atherosclerosis: the
INVADE study. Stroke 2006;37:351-7.
8
Schulze MB, Rimm EB, Li T, et al. C-reactive protein and incident cardiovascular
events among men with diabetes. Diabetes Care 2004;27:889-94.
9
Curb JD, Abbott RD, Rodriguez BL, et al. C-reactive protein and the future risk
of thromboembolic stroke in healthy men. Circulation 2003;107:2016-20.
10
Sakkinen P, Abbott RD, Curb JD, et al. C-reactive protein and myocardial
infarction. J Clin Epidemiol 2002;55:445-51.
11
Bots ML, Hofman A, Grobbee DE. Increased common carotid intima-media
thickness. Adaptive response or a reflection of atherosclerosis? Findings from the
Rotterdam Study. Stroke 1997;28:2442-7.
12
Kablak-Ziembicka A, Przewlocki T, Tracz W, et al. Diagnostic value of carotid
intima-media thickness in indicating multi-level atherosclerosis. Atherosclerosis
2007;193:395-400.
13
Akosah KO, McHugh VL, Barnhart SI, et al. Carotid ultrasound for risk
clarification in young to middle-aged adults undergoing elective coronary angiography.
Am J Hypertens 2006;19:1256-61.
14
Folsom AR, Eckfeldt JH, Weitzman S, et al. Relation of carotid artery wall
thickness to diabetes mellitus, fasting glucose and insulin, body size, and physical
activity. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Stroke
1994;25:66-73.
15
Melidonis A, Kyriazis IA, Georgopali A, et al. Prognostic value of the carotid
artery intima-media thickness for the presence and severity of coronary artery disease in
type 2 diabetic patients. Diabetes Care 2003;26:3189-90.
16
Mitsuhashi N, Onuma T, Kubo S, et al. Coronary artery disease and carotid artery
intima-media thickness in Japanese type 2 diabetic patients. Diabetes Care
2002;25:1308-12.
17
Haffner SM, Agostino RD, Jr., Saad MF, et al. Carotid artery atherosclerosis in
type-2 diabetic and nondiabetic subjects with and without symptomatic coronary artery
disease (The Insulin Resistance Atherosclerosis Study). Am J Cardiol 2000;85:1395-400.
18
Lee CD, Folsom AR, Pankow JS, et al. Cardiovascular events in diabetic and
nondiabetic adults with or without history of myocardial infarction. Circulation
2004;109:855-60.
19
Djaberi R, Schuijf JD, de Koning EJ, et al. Usefulness of Carotid Intima Media
Thickness in Patients with Diabetes Mellitus as a Predictor of Coronary Artery Disease.
. Am J Cardiol 2009;104;1041-6.
20
Salonen JT, Salonen R. Ultrasonographically assessed carotid morphology and
the risk of coronary heart disease. Arterioscler Thromb 1991;11:1245-9.
21
Chambless LE, Heiss G, Folsom AR, et al. Association of coronary heart disease
incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis
Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol 1997;146:483-94.
22
O'Leary DH, Polak JF, Kronmal RA, et al. Carotid-artery intima and media
thickness as a risk factor for myocardial infarction and stroke in older adults.
Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999;340:1422.
23
van der Meer IM, Bots ML, Hofman A, et al. Predictive value of noninvasive
measures of atherosclerosis for incident myocardial infarction: the Rotterdam Study.
Circulation 2004;109:1089-94.
24
Lorenz MW, von Kegler S, Steinmetz H, et al. Carotid intima-media thickening
indicates a higher vascular risk across a wide age range: prospective data from the
Carotid Atherosclerosis Progression Study (CAPS). Stroke 2006;37:87-92.
25
Yamasaki Y, Kodama M, Nishizawa H, et al. Carotid intima-media thickness in
Japanese type 2 diabetic subjects: predictors of progression and relationship with incident
coronary heart disease. Diabetes Care 2000;23:1310-5.
26
Bernard S, Serusclat A, Targe F, et al. Incremental predictive value of carotid
ultrasonography in the assessment of coronary risk in a cohort of asymptomatic type 2
diabetic subjects. Diabetes Care 2005;28:1158-62.
27
Folsom AR, Chambless LE, Duncan BB, et al. Prediction of coronary heart
disease in middle-aged adults with diabetes. Diabetes Care 2003;26:2777-84.
28
Sutton-Tyrrell K, Najjar SS, Boudreau RM, et al. Elevated aortic pulse wave
velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning
older adults. Circulation 2005;111:3384-90.
29
Schram MT, Henry RM, van Dijk RA, et al. Increased central artery stiffness in
impaired glucose metabolism and type 2 diabetes: the Hoorn Study. Hypertension
2004;43:176-81.
30
Sims TJ, Rasmussen LM, Oxlund H, et al. The role of glycation cross-links in
diabetic vascular stiffening. Diabetologia 1996;39:946-51.
31
Kimoto E, Shoji T, Shinohara K, et al. Preferential stiffening of central over
peripheral arteries in type 2 diabetes. Diabetes 2003;52:448-52.
32
Taniwaki H, Kawagishi T, Emoto M, et al. Correlation between the intima-media
thickness of the carotid artery and aortic pulse-wave velocity in patients with type 2
diabetes. Vessel wall properties in type 2 diabetes. Diabetes Care 1999;22:1851-7.
33
Hatsuda S, Shoji T, Shinohara K, et al. Regional arterial stiffness associated with
ischemic heart disease in type 2 diabetes mellitus. J Atheroscler Thromb 2006;13:114-21.
34
Tsuchiya M, Suzuki E, Egawa K, et al. Stiffness and impaired blood flow in
lower-leg arteries are associated with severity of coronary artery calcification among
asymptomatic type 2 diabetic patients. Diabetes Care 2004;27:2409-15.
35
Rakhit DJ, Downey M, Jeffries L, et al. Screening for coronary artery disease in
patients with diabetes: a Bayesian strategy of clinical risk evaluation and exercise
echocardiography. Am Heart J 2005;150:1074-80.
36
Zaret BL, Wackers FJ. Nuclear cardiology (1). N Engl J Med 1993;329:775-83.
37
Rutter MK, Wahid ST, McComb JM, et al. Significance of silent ischemia and
microalbuminuria in predicting coronary events in asymptomatic patients with type 2
diabetes. J Am Coll Cardiol 2002;40:56-61.
38
Faglia E, Favales F, Morabito A. New ulceration, new major amputation, and
survival rates in diabetic subjects hospitalized for foot ulceration from 1990 to 1993: a
6.5-year follow-up. Diabetes Care 2001;24:78-83.
39
Miyamoto MI, Vernotico SL, Majmundar H, et al. Pharmacologic stress
myocardial perfusion imaging: a practical approach. J Nucl Cardiol 2007;14:250-5.
40
Kang X, Berman DS, Lewin H, et al. Comparative ability of myocardial perfusion
single-photon emission computed tomography to detect coronary artery disease in
patients with and without diabetes mellitus. Am Heart J 1999;137:949-57.
41
Shaw LJ, Iskandrian AE. Prognostic value of gated myocardial perfusion SPECT.
J Nucl Cardiol 2004;11:171-85.
42
Freeman M. Myocardial perfusion imaging in diabetes mellitus. Can J Cardiol
2006;22 Suppl A:22A-5A.
43
Kang X, Berman DS, Lewin HC, et al. Incremental prognostic value of
myocardial perfusion single photon emission computed tomography in patients with
diabetes mellitus. Am Heart J 1999;138:1025-32.
44
Giri S, Shaw LJ, Murthy DR, et al. Impact of diabetes on the risk stratification
using stress single-photon emission computed tomography myocardial perfusion imaging
in patients with symptoms suggestive of coronary artery disease. Circulation
2002;105:32-40.
45
Russell RR, 3rd, Zaret BL. Nuclear cardiology: present and future. Curr Probl
Cardiol 2006;31:557-629.
46
Go RT, Marwick TH, MacIntyre WJ, et al. A prospective comparison of
rubidium-82 PET and thallium-201 SPECT myocardial perfusion imaging utilizing a
single dipyridamole stress in the diagnosis of coronary artery disease. J Nucl Med
1990;31:1899-905.
47
Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized Myocardial
Segmentation and Nomenclature for Tomographic Imaging of the Heart. A Statement for
Healthcare Professionals From the Cardiac Imaging Committee of the Council on
Clinical Cardiology of the American Heart Association American Heart Association
Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. .
Circulation 2003;105:539-42.
48
Hennessy TG, Codd MB, Kane G, et al. Evaluation of patients with diabetes
mellitus for coronary artery disease using dobutamine stress echocardiography. Coron
Artery Dis 1997;8:171-4.
49
Penfornis A, Zimmermann C, Boumal D, et al. Use of dobutamine stress
echocardiography in detecting silent myocardial ischaemia in asymptomatic diabetic
patients: a comparison with thallium scintigraphy and exercise testing. Diabet Med
2001;18:900-5.
50
Schuijf JD, Poldermans D, Shaw LJ, et al. Diagnostic and prognostic value of
non-invasive imaging in known or suspected coronary artery disease. Eur J Nucl Med
Mol Imaging 2006;33:93-104.
51
Marwick TH, Case C, Sawada S, et al. Use of stress echocardiography to predict
mortality in patients with diabetes and known or suspected coronary artery disease.
Diabetes Care 2002;25:1042-8.
52
Elhendy A, Arruda AM, Mahoney DW, et al. Prognostic stratification of diabetic
patients by exercise echocardiography. J Am Coll Cardiol 2001;37:1551-7.
53
Kamalesh M, Matorin R, Sawada S. Prognostic value of a negative stress
echocardiographic study in diabetic patients. Am Heart J 2002;143:163-8.
54
Cortigiani L, Bigi R, Sicari R, et al. Prognostic value of pharmacological stress
echocardiography in diabetic and nondiabetic patients with known or suspected coronary
artery disease. J Am Coll Cardiol 2006;47:605-10.
55
Elhendy A, O'Leary EL, Xie F, et al. Comparative accuracy of real-time
myocardial contrast perfusion imaging and wall motion analysis during dobutamine stress
echocardiography for the diagnosis of coronary artery disease. J Am Coll Cardiol
2004;44:2185-91.
56
Tsutsui JM, Elhendy A, Anderson JR, et al. Prognostic value of dobutamine stress
myocardial contrast perfusion echocardiography. Circulation 2005;112:1444-50.
57
Rerkpattanapipat P, Hundley WG. Dobutamine stress magnetic resonance
imaging. Echocardiography 2007;24:309-15.
58
Paetsch I, Jahnke C, Wahl A, et al. Comparison of dobutamine stress magnetic
resonance, adenosine stress magnetic resonance, and adenosine stress magnetic resonance
perfusion. Circulation 2004;110:835-42.
59
Jahnke C, Nagel E, Gebker R, et al. Prognostic value of cardiac magnetic
resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion
imaging. Circulation 2007;115:1769-76.
60
Agatston AS, Janowitz WR, Hildner FJ, et al. Quantification of coronary artery
calcium using ultrafast computed tomography. J Am Coll Cardiol 1990;15:827-32.
61
Schurgin S, Rich S, Mazzone T. Increased prevalence of significant coronary
artery calcification in patients with diabetes. Diabetes Care 2001;24:335-8.
62
Mielke CH, Shields JP, Broemeling LD. Coronary artery calcium, coronary artery
disease, and diabetes. Diabetes Res Clin Pract 2001;53:55-61.
63
Khaleeli E, Peters SR, Bobrowsky K, et al. Diabetes and the associated incidence
of subclinical atherosclerosis and coronary artery disease: Implications for management.
Am Heart J 2001;141:637-44.
64
Budoff MJ, Shaw LJ, Liu ST, et al. Long-term prognosis associated with coronary
calcification: observations from a registry of 25,253 patients. J Am Coll Cardiol
2007;49:1860-70.
65
Anand DV, Lim E, Hopkins D, et al. Risk stratification in uncomplicated type 2
diabetes: prospective evaluation of the combined use of coronary artery calcium imaging
and selective myocardial perfusion scintigraphy. Eur Heart J 2006;27:713-21.
66
Schuijf JD, Jukema JW, van der Wall EE, et al. The current status of multislice
computed tomography in the diagnosis and prognosis of coronary artery disease. J Nucl
Cardiol 2007;14:604-12.
67
Burgstahler C, Beck T, Reimann A, et al. Diagnostic accuracy of multislice
computed tomography for the detection of coronary artery disease in diabetic patients. J
Diabetes Complications 2007;21:69-74.
68
Schuijf JD, Bax JJ, Jukema JW, et al. Noninvasive angiography and assessment of
left ventricular function using multislice computed tomography in patients with type 2
diabetes. Diabetes Care 2004;27:2905-10.
69
Schroeder S, Kopp AF, Baumbach A, et al. Noninvasive detection and evaluation
of atherosclerotic coronary plaques with multislice computed tomography. J Am Coll
Cardiol 2001;37:1430-5.
70
Pundziute G, Schuijf JD, Jukema JW, et al. Noninvasive assessment of plaque
characteristics with multislice computed tomography coronary angiography in
symptomatic diabetic patients. Diabetes Care 2007;30:1113-9.
71
Pundziute G, Schuijf JD, Jukema JW, et al. Type 2 diabetes is associated with
more advanced coronary atherosclerosis on multislice computed tomography and virtual
histology intravascular ultrasound. J Nucl Cardiol 2009;16:376-83.
72
Scholte AJ, Schuijf JD, Kharagjitsingh AV, et al. Prevalence of coronary artery
disease and plaque morphology assessed by multi-slice computed tomography coronary
angiography and calcium scoring in asymptomatic patients with type 2 diabetes. Heart
2008;94:290-5.
73
Cademartiri F, Seitun S, Romano M, et al. Prognostic value of 64-slice coronary
angiography in diabetes mellitus patients with known or suspected coronary artery
disease compared with a nondiabetic population. Radiol Med 2008;113:627-43.
74
Manning WJ, Li W, Edelman RR. A preliminary report comparing magnetic
resonance coronary angiography with conventional angiography. N Engl J Med
1993;328:828-32.
75
Di Carli MF, Dorbala S, Meserve J, et al. Clinical myocardial perfusion PET/CT.
J Nucl Med 2007;48:783-93.
76
Grundy SM, Benjamin IJ, Burke GL, et al. Diabetes and cardiovascular disease: a
statement for healthcare professionals from the American Heart Association. Circulation
1999;100:1134-46.
77
Consensus development conference on the diagnosis of coronary heart disease in
people with diabetes: 10-11 February 1998, Miami, Florida. American Diabetes
Association. Diabetes Care 1998;21:1551-9.